| abstract |
The present invention provides a chemical selected from the group consisting of compounds of formula (I), wherein R1, R2 and m have the meanings specified in the specification, as well as pharmaceutically acceptable salts, solvates, and stereoisomers thereof, It is an inhibitor of ATR and has potential for use in the treatment of cancer. The present invention provides a pharmaceutical composition of such chemical substances, a combination product containing the same, a use of the compositions as a therapeutic agent, and a method of treating using such compositions. |